In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. A federal jury in Delaware ...

Biotechnology company, Amgen, has announced that it has entered into a definitive agreement to acquire deCODE Genetics, a global leader in human genetics, for US $415 million. The all-cash ...

Amgen recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to strengthen its biomanufacturing capabilities. This investment is part of a strategic ...

Biotechnology company Amgen announced a $900 million expansion of its New Albany facility on Friday. The expansion will add 350 new jobs in central Ohio. Several leaders are set to speak at an ...

Amgen will invest $900 million to expand its New Albany manufacturing facility and add 350 jobs in what is the largest life sciences and pharmaceutical manufacturing expansion in the history of Ohio.

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

RBC lowers Amgen price target to $320 but keeps Outperform rating based on steady outlook for MariTide. Goldman sees MariTide efficacy risk in Phase 3 trial due to dose escalation, possibly ...

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws ...